Rene Sindlev, Director, 10% Owner at Enochian Biosciences Inc (ENOB), bought 20,000 shares at $5.75 ($115K) on 2019-05-21, disclosed to the SEC on 2019-05-23.
Open-market purchase of $115k ENOB by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| ENOB | BUY | 2019-06-05 | $132K | — | Filing → |
| ENOB | BUY | 2019-06-05 | $31K | — | Filing → |
| ENOB | BUY | 2019-06-05 | $268K | — | Filing → |